DRDO’s anti-COVID oral drug ‘2-DG’ gets DCGI nod, for emergency use
New Delhi, May 8 (UNI) The Drug Controller General of India (DCGI) has approved the emergency use of DRDO's anti-COVID-19 therapeutic oral drug 2-deoxy-D-glucose (2-DG) as adjunct therapy in moderate to severe COVID-19 patients. On May 1,…